US Broker Ratings

Semler Scientific, Inc. (SMLR) Stock Analysis: Examining the 258% Potential Upside for Investors

Semler Scientific, Inc. (NASDAQ: SMLR), a prominent player in the medical devices sector, is currently capturing investor attention with its remarkable potential upside of 258.65%. This healthcare company, specializing in..

Immunome, Inc. (IMNM) Investor Outlook: Exploring a Promising 60% Upside in the Biotech Sector

Immunome, Inc. (IMNM), a United States-based clinical-stage biotechnology company, has been making waves in the healthcare sector with its innovative approach to developing targeted cancer therapies. As the company continues..

Celcuity Inc. (CELC)

⚠️ No article content returned.

..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Evaluating the 13.23% Potential Upside for Investors

For investors eyeing opportunities in the healthcare sector, Cross Country Healthcare, Inc. (NASDAQ: CCRN) presents an intriguing case. Specializing in providing talent management services for healthcare clients across the United..

CeriBell, Inc. (CBLL) Stock Analysis: Exploring a 43% Potential Upside in the Innovative Medical Devices Sector

CeriBell, Inc. (CBLL) is making waves in the healthcare sector with its pioneering approach to neurological diagnostics. As a medical technology company specializing in the development of advanced electroencephalography (EEG)..

Weave Communications, Inc. (WEAV) Stock Analysis: Exploring a Potential 74% Upside in the Health Information Services Sector

Weave Communications, Inc. (NASDAQ: WEAV) is making waves in the health information services sector, offering investors intriguing growth potential. With a market capitalization of $391.69 million, this U.S.-based company focuses..

Eton Pharmaceuticals (ETON) Stock Analysis: Exploring a 73.91% Upside Potential in the Rare Disease Market

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is attracting considerable attention in the healthcare sector, particularly among investors focused on specialty and generic drug manufacturers. Despite its relatively modest market capitalization of..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: A Promising Biotech with a Potential 227% Upside

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a pioneering force in the biotechnology sector, is making headlines with its strategic focus on the cutting-edge development of therapeutic proteins and antibodies. This Watertown,..

Fortrea Holdings Inc. (FTRE): Investor Outlook with a Promising 37.88% Potential Upside

Fortrea Holdings Inc. (FTRE), a burgeoning player in the healthcare sector, is capturing attention with its potential upside of 37.88%, as indicated by analyst ratings. Despite a challenging landscape characterized..

Xencor, Inc. (XNCR) Investor Outlook: Unpacking the 113% Potential Upside in Biotech Innovation

Xencor, Inc. (XNCR), a clinical-stage biopharmaceutical company, is attracting a lot of investor attention in the biotechnology sector, driven by its innovative approach to treating various diseases. With a market..

Inventiva S.A. (IVA) Stock Analysis: A 136% Upside Potential Amidst Robust Revenue Growth

Inventiva S.A. (NASDAQ: IVA), a prominent player in the biopharmaceutical sector, is capturing investor attention with a remarkable 136% potential upside. With a current market capitalization of $1.36 billion, this..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating a 60% Upside Potential Amidst Financial Challenges

Myriad Genetics, Inc. (NASDAQ: MYGN) stands at a pivotal juncture as it navigates the complex landscape of molecular diagnostics and precision medicine. With a market capitalization of $453.02 million, this..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Biotech Innovator with a 10.77% Potential Upside

Maze Therapeutics, Inc. (NASDAQ: MAZE), a promising player in the biotechnology sector, has caught the attention of investors with its innovative approach to treating renal, cardiovascular, and metabolic diseases. Despite..

COMPASS Pathways (CMPS) Stock Analysis: Unveiling a Potential 164.89% Upside in the Psychedelic Therapy Space

COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering company in the development of innovative mental health therapies, is capturing the attention of investors with its promising product pipeline and significant upside..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Unveiling a Potential 205% Upside in the Biotech Sector

Investors eyeing the biotechnology sector should take a close look at Niagen Bioscience, Inc. (NAGE), a company poised for substantial growth. With a market cap of $413.4 million, this U.S.-based..

Valneva SE (VALN) Stock Analysis: Potential Upside Amidst Challenging Metrics

Valneva SE (NASDAQ: VALN), a French biotechnology firm specializing in vaccines for infectious diseases, has garnered attention from investors, particularly due to its promising pipeline of prophylactic vaccines. Despite its..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Growth Amidst Challenges

Sonida Senior Living, Inc. (SNDA), operating within the healthcare sector as a key player in the medical care facilities industry, is currently under the spotlight for its recent financial performance..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Unveiling a Potential 116% Upside in Healthcare Innovation

Organogenesis Holdings Inc. (NASDAQ: ORGO), a leading regenerative medicine company based in Canton, Massachusetts, presents a compelling narrative for investors with a keen interest in healthcare innovation. With a market..

Cel-Sci Corporation (CVM): Unpacking the 832% Upside Potential for This Biotech Innovator

Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotechnology company based in Vienna, Virginia, is making waves in the healthcare sector with its groundbreaking approach to immunotherapy. Specializing in harnessing the immune..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A Biotech Powerhouse with 76% Upside Potential

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is a clinical-stage biopharmaceutical company that has captured the attention of investors due to its promising pipeline in the healthcare sector’s biotechnology industry. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds